230 related articles for article (PubMed ID: 12709027)
21. Identification of interdependent variables that influence coreceptor switch in R5 SHIV(SF162P3N)-infected macaques.
Zhuang K; Finzi A; Toma J; Frantzell A; Huang W; Sodroski J; Cheng-Mayer C
Retrovirology; 2012 Dec; 9():106. PubMed ID: 23237529
[TBL] [Abstract][Full Text] [Related]
22. The role of viral coreceptors and enhanced macrophage tropism in human immunodeficiency virus type 1 disease progression.
Gorry PR; Sterjovski J; Churchill M; Witlox K; Gray L; Cunningham A; Wesselingh S
Sex Health; 2004; 1(1):23-34. PubMed ID: 16335478
[TBL] [Abstract][Full Text] [Related]
23. Multiple determinants are involved in HIV coreceptor use as demonstrated by CCR4/CCL22 interaction in peripheral blood mononuclear cells (PBMCs).
Agrawal L; Vanhorn-Ali Z; Alkhatib G
J Leukoc Biol; 2002 Nov; 72(5):1063-74. PubMed ID: 12429730
[TBL] [Abstract][Full Text] [Related]
24. CCR6 functions as a new coreceptor for limited primary human and simian immunodeficiency viruses.
Islam S; Shimizu N; Hoque SA; Jinno-Oue A; Tanaka A; Hoshino H
PLoS One; 2013; 8(8):e73116. PubMed ID: 24009735
[TBL] [Abstract][Full Text] [Related]
25. Effects of human immunodeficiency virus type 1 infection on CCR5 and CXCR4 coreceptor expression on CD4 T lymphocyte subsets in infants and adolescents.
Tuttle DL; Coberley CR; Xie X; Kou ZC; Sleasman JW; Goodenow MM
AIDS Res Hum Retroviruses; 2004 Mar; 20(3):305-13. PubMed ID: 15117454
[TBL] [Abstract][Full Text] [Related]
26. CXCR4 and CCR5 regulation and expression patterns on T- and monocyte-macrophage cell lineages: implications for susceptibility to infection by HIV-1.
Joly M; Pinto JM
Math Biosci; 2005 May; 195(1):92-126. PubMed ID: 15893340
[TBL] [Abstract][Full Text] [Related]
27. Identification of a subset of human immunodeficiency virus type 1 (HIV-1), HIV-2, and simian immunodeficiency virus strains able to exploit an alternative coreceptor on untransformed human brain and lymphoid cells.
Willey SJ; Reeves JD; Hudson R; Miyake K; Dejucq N; Schols D; De Clercq E; Bell J; McKnight A; Clapham PR
J Virol; 2003 Jun; 77(11):6138-52. PubMed ID: 12743271
[TBL] [Abstract][Full Text] [Related]
28. Coreceptor/chemokine receptor expression on human hematopoietic cells: biological implications for human immunodeficiency virus-type 1 infection.
Lee B; Ratajczak J; Doms RW; Gewirtz AM; Ratajczak MZ
Blood; 1999 Feb; 93(4):1145-56. PubMed ID: 9949156
[TBL] [Abstract][Full Text] [Related]
29. How HIV changes its tropism: evolution and adaptation?
Mosier DE
Curr Opin HIV AIDS; 2009 Mar; 4(2):125-30. PubMed ID: 19339951
[TBL] [Abstract][Full Text] [Related]
30. Proinflammatory oscillations over the menstrual cycle drives bystander CD4 T cell recruitment and SHIV susceptibility from vaginal challenge.
Swaims-Kohlmeier A; Sheth AN; Brody J; Hardnett FP; Sharma S; Bonning EW; Ofotokun I; Massud I; García-Lerma JG
EBioMedicine; 2021 Jul; 69():103472. PubMed ID: 34229275
[TBL] [Abstract][Full Text] [Related]
31. Lineage-specific expression of human immunodeficiency virus (HIV) receptor/coreceptors in differentiating hematopoietic precursors: correlation with susceptibility to T- and M-tropic HIV and chemokine-mediated HIV resistance.
Chelucci C; Casella I; Federico M; Testa U; Macioce G; Pelosi E; Guerriero R; Mariani G; Giampaolo A; Hassan HJ; Peschle C
Blood; 1999 Sep; 94(5):1590-600. PubMed ID: 10477684
[TBL] [Abstract][Full Text] [Related]
32. Evolution of coreceptor use and CD4-independence in envelope clones derived from SIVsm-infected macaques.
Vödrös D; Thorstensson R; Doms RW; Fenyö EM; Reeves JD
Virology; 2003 Nov; 316(1):17-28. PubMed ID: 14599787
[TBL] [Abstract][Full Text] [Related]
33. Putative cholesterol-binding sites in human immunodeficiency virus (HIV) coreceptors CXCR4 and CCR5.
Zhukovsky MA; Lee PH; Ott A; Helms V
Proteins; 2013 Apr; 81(4):555-67. PubMed ID: 23161741
[TBL] [Abstract][Full Text] [Related]
34. Evolution of human immunodeficiency virus type 2 coreceptor usage, autologous neutralization, envelope sequence and glycosylation.
Shi Y; Brandin E; Vincic E; Jansson M; Blaxhult A; Gyllensten K; Moberg L; Broström C; Fenyö EM; Albert J
J Gen Virol; 2005 Dec; 86(Pt 12):3385-3396. PubMed ID: 16298986
[TBL] [Abstract][Full Text] [Related]
35. Existence of Replication-Competent Minor Variants with Different Coreceptor Usage in Plasma from HIV-1-Infected Individuals.
Maeda Y; Takemura T; Chikata T; Kuwata T; Terasawa H; Fujimoto R; Kuse N; Akahoshi T; Murakoshi H; Tran GV; Zhang Y; Pham CH; Pham AHQ; Monde K; Sawa T; Matsushita S; Nguyen TV; Nguyen KV; Hasebe F; Yamashiro T; Takiguchi M
J Virol; 2020 Jun; 94(12):. PubMed ID: 32295903
[TBL] [Abstract][Full Text] [Related]
36. Human Immunodeficiency Virus Immune Cell Receptors, Coreceptors, and Cofactors: Implications for Prevention and Treatment.
Woodham AW; Skeate JG; Sanna AM; Taylor JR; Da Silva DM; Cannon PM; Kast WM
AIDS Patient Care STDS; 2016 Jul; 30(7):291-306. PubMed ID: 27410493
[TBL] [Abstract][Full Text] [Related]
37. Differential effects of R5 and X4 human immunodeficiency virus type 1 infection on CD4+ cell proliferation and activation.
Locher CP; Witt SA; Kassel R; Dowell NL; Fujimura S; Levy JA
J Gen Virol; 2005 Apr; 86(Pt 4):1171-1179. PubMed ID: 15784911
[TBL] [Abstract][Full Text] [Related]
38. A cell line-based neutralization assay for primary human immunodeficiency virus type 1 isolates that use either the CCR5 or the CXCR4 coreceptor.
Trkola A; Matthews J; Gordon C; Ketas T; Moore JP
J Virol; 1999 Nov; 73(11):8966-74. PubMed ID: 10516002
[TBL] [Abstract][Full Text] [Related]
39. GB virus C coinfection in advanced HIV type-1 disease is associated with low CCR5 and CXCR4 surface expression on CD4(+) T-cells.
Schwarze-Zander C; Neibecker M; Othman S; Tural C; Clotet B; Blackard JT; Kupfer B; Luechters G; Chung RT; Rockstroh JK; Spengler U
Antivir Ther; 2010; 15(5):745-52. PubMed ID: 20710056
[TBL] [Abstract][Full Text] [Related]
40. Coreceptor usage of BOB/GPR15 and Bonzo/STRL33 by primary isolates of human immunodeficiency virus type 1.
P Hlmann S; Krumbiegel M; Kirchhoff F
J Gen Virol; 1999 May; 80 ( Pt 5)():1241-1251. PubMed ID: 10355771
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
